-
Does calcitriol have a positive effect on the treatment of rickets?
Time of Update: 2021-08-29
It can promote the redevelopment of the body and prevent children from developing rickets, unsound bones and loss of bone density during the growth and development process .
-
Necessary for diagnosis and treatment: "hypophosphatemic rickets", a rare endocrine disease
Time of Update: 2021-04-23
At the same time, FGF23 can inhibit the activity of 1α-hydroxylase in the kidney, reduce the production of 1,25(OH)2D, reduce the absorption of calcium and phosphorus in the intestine, and further aggravate hypophosphatemia, leading to bone mineralization disorders and causing rickets Or the performance of osteomalacia.
-
FDA approves Alnylam's RNAi drug givlaari (givosiran) for the treatment of acute hepatic rickets
Time of Update: 2020-06-07
The u.S Food and Drug (http:// Administration (http:// has approved another of its RNAi drug, Givlaari (givosiran), which is given through subcutaneous injections to treat adult patients with a
-
FDA Approves the first genetic rickets drug
Time of Update: 2018-04-18
Source: US and Chinese drug sources April 18, 2018 FDA approved the FGF23 antibody burosumab (trade name: crysvita ®) jointly developed by ultragenyx (rare) / Kyowa Kirin for the treatment of X-linked
-
Japanese scientists have successfully developed a new high-temperature resin material using enzymes produced by ricket-caused bacteria
Time of Update: 2021-01-13
, led by Yoshida Cheng (Microbiology), an associate professor in the Department of Agology at Tokyo Agricultural and Industrial University in Japan, recently announced that they have successfully developed a new resin material using enzymes produced by rickets- bacteria.